Orally active MMP inhibitor for the treatment of bone cancer pain
Ended Cooperative Agreement Awarded Last action
- Award ID
- R43CA199695
- Recipient
-
Aquilus Pharmaceuticals, Inc. UEI EM9ULMXK5F21
- Awarding agency
-
National Institutes of Health
Department of Health and Human Services
- Obligated
- $287,199
Award facts
- Assistance listing
- 93.395 Cancer Treatment Research
- Completion date
- Originally
- Funding agency
- Department of Health and Human Services
- Place of performance
- Woburn, MA 01801, USA
Award details come from USAspending.gov.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Amendment | $0 | |
| Original award | $287,199 |
Quick answers
Who received award R43CA199695?
R43CA199695 was awarded to Aquilus Pharmaceuticals, Inc. by National Institutes of Health (Department of Health and Human Services) on September 23, 2015.
How much is award R43CA199695 worth?
$287,199 has been obligated on R43CA199695.
Which agency awarded R43CA199695?
National Institutes of Health (Department of Health and Human Services) awarded R43CA199695, with funding from Department of Health and Human Services.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award